We Are EnteraSense

EnteraSense is a Medical Device company committed to the innovation and commercialisation of GI sensor technologies. We aim to transform and add value to the diagnosis and monitoring of Upper Gastrointestinal bleeding. We are dedicated to improving patient outcomes by allowing a quicker and more accurate diagnosis.

The device is ingested similar to other existing capsule endoscopic devices in accordance with current clinical practice. Once the device is initiated, it will start detecting immediately using optical technology and can be used to monitor the presence of UGIB for a period up to 3 days. The data is wirelessly transmitted to an external monitor (PC, mobile phone, custom receiver, etc.) enabling a real-time diagnosis.

This product addresses UGIB both as an inpatient and in a triage setting. Today in the United States 1.1M patients attend ER for suspected bleeding but only two thirds of them are diagnosed with actual bleeding. This device offers a solution for the emergency room to triage patients more efficiently. Additionally, of the patients hospitalised with UGIB, a high percentage are high-risk and require monitoring after treatment. This device offers a unique solution for real-time monitoring of these patients for up to 3 days.